...On Jan. 18, metabolic medical device company EnteroMedics Inc. (NASDAQ:ETRM) raised $16.5 million through the sale of...
...five-year warrants to purchase up to 188 shares at $5.84. EnteroMedics Inc. (NASDAQ:ETRM), St. Paul, Minn. Alex Himes EnteroMedics Inc....

...of business development and alliance management at bluebird bio Inc. (NASDAQ:BLUE). CNS and metabolic company EnteroMedics Inc....

...decisions. Last year, CDRH used patient preference data to approve the Maestro Rechargeable System from EnteroMedics Inc....

...relations at Gruenenthal Group (Aachen, Germany) and SVP of government relations and health policy at EnteroMedics Inc....

...has been approved based on data from patient preference studies. The Maestro Rechargeable System from EnteroMedics Inc....
...and PPMD's activities," said Boutin. Companies and Institutions Mentioned Biotechnology Industry Organization (BIO), Washington, D.C. EnteroMedics Inc....

...$25 million Shares outstanding prior: 106.4 million Placement agent: Northland Securities Investor: Institutional investors Note: EnteroMedics...

...short of a patient-reported outcome." Companies and Institutions Mentioned Biotechnology Industry Organization (BIO), Washington, D.C. EnteroMedics Inc....
...preference survey it had commissioned to approve an obesity device, the Maestro Rechargeable System from EnteroMedics Inc....

...Obesity device company EnteroMedics Inc. (NASDAQ:ETRM) named Scott Shikora EVP of medical affairs and CMO, effective June...